Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-01

AUTHORS

Tong Zhou, Ling Song, Pingar Yang, Zheng Wang, Di Lui, Richard S. Jope

ABSTRACT

Fas-mediated apoptosis is essential for the elimination of cells, and impaired apoptosis can have severe detrimental consequences. Bisindolylmaleimide VIII potentiated Fas-mediated apoptosis in human astrocytoma 1321N1 cells and in Molt-4 T cells, both of which were devoid of apoptosis induced by anti-Fas antibody in the absence of bisindolylmaleimide VIII, and in Jurkat and CEM-6 T cells, which showed slight and moderate apoptotic responses, respectively, to low levels of Fas stimulation. Potentiation of Fas-mediated apoptosis by bisindolylmaleimide VIII was selective for activated, rather than non-activated, T cells, and was Fas-dependent, as it was not observed in T cells from Fas-deficient lpr/lpr mice. Administration of bisindolylmaleimide VIII to rats during autoantigen stimulation prevented the development of symptoms of T cell-mediated autoimmune diseases in two models, the Lewis rat model of experimental allergic encephalitis and the Lewis adjuvant arthritis model. Thus, the use of agents such as bisindolylmaleimide VIII may be therapeutically useful for supporting more effective elimination of detrimental cells through enhancement of Fas-dependent apoptosis signaling. More... »

PAGES

42-48

Journal

TITLE

Nature Medicine

ISSUE

1

VOLUME

5

Related Patents

  • Substituted 4h-Chromenes And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 2-Aryl-4-Arylaminopyrimidines And Analogs As Activators Or Caspases And Inducers Of Apoptosis And The Use Thereof
  • 7,8-Fused 4h-Chromene And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted Nicotinamides And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 4h-Chromens, 2h-Chromenes, Chromans And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Agents And Methods Related To Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
  • 3,5-Disubstituted-[1,2,4]-Oxadiazoles And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 2-Aryl-4-Arylaminopyrimidines And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Agents And Methods Related To Screening For Resistance To Dr5 And Reducing Resistance To Dr5 Agonists
  • Use Of Bisindolylmaleimide Compounds To Induce Fas-Mediated Apoptosis
  • Multifluoro-Substituted Chalcones And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Derivatives Of Gambogic Acid And Analogs As Activators Of Caspases And Inducers Of Apoptosis
  • 3,5-Disubstituted-[1,2,4]-Oxadiazoles And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • 4-Substituted-1-(Arylmethylidene)Thiosemicarbazide, 4-Substituted-1-(Arylcarbonyl)Thiosemicarbazide And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted Indole-2-Carboxylic Acid Benzylidene-Hydrazides And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 1, 4-Thiazepine And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Fluorogenic Or Fluorescent Reporter Molecules And Their Applications For Whole-Cell Fluorescence Screening Assays For Caspases And Other Enzymes And The Use Thereof
  • Agents And Methods Related To Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
  • Gambogic Acid, Analogs And Derivatives As Activators Of Caspases And Inducers Of Apoptosis
  • Method Of Identifying Immunosuppressive Agents
  • Substituted 3-Aryl-5-Aryl-[1,2,4]-Oxadiazoles And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 4-Aryl-4h-Pyrrolo[2,3-H]Chromenes And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 4h-Chromene And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Method Of Using Substituted 3-Aryl-5-Aryl-[1,2,4]-Oxadiazoles And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Substituted 4h-Chromene And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof
  • Derivatives Of Gambogic Acid And Analogs As Activators Of Caspases And Inducers Of Apoptosis
  • Gambogic Acid, Analogs And Derivatives As Activators Of Caspases And Inducers Of Apoptosis
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/4723

    DOI

    http://dx.doi.org/10.1038/4723

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1001523482

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9883838


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Arthritis, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Autoimmune Diseases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Models, Animal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Encephalomyelitis, Autoimmune, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Indoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Jurkat Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphocyte Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Maleimides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred MRL lpr", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Kinase C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats, Inbred Lew", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "T-Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Necrosis Factor-alpha", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "fas Receptor", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhou", 
            "givenName": "Tong", 
            "id": "sg:person.0664616100.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Song", 
            "givenName": "Ling", 
            "id": "sg:person.0724445616.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724445616.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yang", 
            "givenName": "Pingar", 
            "id": "sg:person.016612437322.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612437322.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Zheng", 
            "id": "sg:person.01117126520.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117126520.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lui", 
            "givenName": "Di", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jope", 
            "givenName": "Richard S.", 
            "id": "sg:person.01076605634.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076605634.02"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/373438a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045725490", 
              "https://doi.org/10.1038/373438a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/332843a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030288808", 
              "https://doi.org/10.1038/332843a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/373441a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049599122", 
              "https://doi.org/10.1038/373441a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/356314a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041635124", 
              "https://doi.org/10.1038/356314a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/373444a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037666095", 
              "https://doi.org/10.1038/373444a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4615-1891-4_18", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026925757", 
              "https://doi.org/10.1007/978-1-4615-1891-4_18"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1999-01", 
        "datePublishedReg": "1999-01-01", 
        "description": "Fas-mediated apoptosis is essential for the elimination of cells, and impaired apoptosis can have severe detrimental consequences. Bisindolylmaleimide VIII potentiated Fas-mediated apoptosis in human astrocytoma 1321N1 cells and in Molt-4 T cells, both of which were devoid of apoptosis induced by anti-Fas antibody in the absence of bisindolylmaleimide VIII, and in Jurkat and CEM-6 T cells, which showed slight and moderate apoptotic responses, respectively, to low levels of Fas stimulation. Potentiation of Fas-mediated apoptosis by bisindolylmaleimide VIII was selective for activated, rather than non-activated, T cells, and was Fas-dependent, as it was not observed in T cells from Fas-deficient lpr/lpr mice. Administration of bisindolylmaleimide VIII to rats during autoantigen stimulation prevented the development of symptoms of T cell-mediated autoimmune diseases in two models, the Lewis rat model of experimental allergic encephalitis and the Lewis adjuvant arthritis model. Thus, the use of agents such as bisindolylmaleimide VIII may be therapeutically useful for supporting more effective elimination of detrimental cells through enhancement of Fas-dependent apoptosis signaling.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/4723", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2546217", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2567549", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2434637", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2667883", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1113716", 
            "issn": [
              "1078-8956", 
              "1546-170X"
            ], 
            "name": "Nature Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "5"
          }
        ], 
        "keywords": [
          "cell-mediated autoimmune disease", 
          "autoimmune diseases", 
          "T cells", 
          "Fas-deficient lpr/lpr mice", 
          "lpr/lpr mice", 
          "Fas-mediated apoptosis", 
          "experimental allergic encephalitis", 
          "Lewis rat model", 
          "adjuvant arthritis model", 
          "development of symptoms", 
          "human astrocytoma 1321N1 cells", 
          "astrocytoma 1321N1 cells", 
          "autoantigen stimulation", 
          "allergic encephalitis", 
          "lpr mice", 
          "arthritis model", 
          "Fas-dependent apoptosis", 
          "rat model", 
          "more effective elimination", 
          "use of agents", 
          "severe detrimental consequences", 
          "MOLT-4 T cells", 
          "anti-Fas antibody", 
          "apoptosis", 
          "elimination of cells", 
          "disease", 
          "detrimental cells", 
          "stimulation", 
          "cells", 
          "apoptotic response", 
          "VIII", 
          "low levels", 
          "detrimental consequences", 
          "Potentiation of Fas", 
          "encephalitis", 
          "symptoms", 
          "rats", 
          "potentiation", 
          "effective elimination", 
          "mice", 
          "administration", 
          "FA", 
          "Fas stimulation", 
          "antibodies", 
          "bisindolylmaleimide VIII", 
          "elimination", 
          "Jurkat", 
          "agents", 
          "response", 
          "absence", 
          "levels", 
          "use", 
          "development", 
          "consequences", 
          "model", 
          "enhancement"
        ], 
        "name": "Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases", 
        "pagination": "42-48", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1001523482"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/4723"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9883838"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/4723", 
          "https://app.dimensions.ai/details/publication/pub.1001523482"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:20", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_313.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/4723"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/4723'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/4723'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/4723'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/4723'


     

    This table displays all metadata directly associated to this object as RDF triples.

    274 TRIPLES      22 PREDICATES      111 URIs      97 LITERALS      29 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/4723 schema:about N000b1ce5a3e14c00bcac5750e62f568b
    2 N0ad18f11321e4b56ba167b1374935aa6
    3 N11269747941444748e0c9e482aa4a3db
    4 N1d0cb05d77064ed0b54af6d1d8ada675
    5 N211d33258e2e4a97aa13281316ae42a0
    6 N32b633ae1b6c49b084cf4a547014f72c
    7 N3acfbc410acd4d0dbe3902eaf30cb2aa
    8 N420d6d0b114b457097c327a426b09b73
    9 N586899d6e2254b3f88a9502913dab3e2
    10 N6fb0c12b61f44a869ee463cae739ddd4
    11 N7073c5743cf6499f943027a989e43343
    12 N77f03af1a3e045c7b772651157cb4c6e
    13 N91ee753773044917aba16f7eb5e3c103
    14 Na8d4a0ec6b0f4d568e4f7f2079274e48
    15 Nb6f81b2ddfef424fb9cfb4dc69c512a6
    16 Nbbaf71b217044e158a30a008503dceb6
    17 Nc27fa456b14840d5b3ee815efaeca381
    18 Nd377ae7010604cd2966680b78f88eb14
    19 Nd8ca504bf7a24edb95a89af18cbd1169
    20 Ndc773819fbaf43ae93c8dbf148f3961a
    21 Ndca9994a956f4a909ab1181b92b5eee5
    22 Nea98e90fd533442f886dc32607392885
    23 anzsrc-for:11
    24 anzsrc-for:1107
    25 schema:author N60c24a234a1e422e92762d8c57c32e49
    26 schema:citation sg:pub.10.1007/978-1-4615-1891-4_18
    27 sg:pub.10.1038/332843a0
    28 sg:pub.10.1038/356314a0
    29 sg:pub.10.1038/373438a0
    30 sg:pub.10.1038/373441a0
    31 sg:pub.10.1038/373444a0
    32 schema:datePublished 1999-01
    33 schema:datePublishedReg 1999-01-01
    34 schema:description Fas-mediated apoptosis is essential for the elimination of cells, and impaired apoptosis can have severe detrimental consequences. Bisindolylmaleimide VIII potentiated Fas-mediated apoptosis in human astrocytoma 1321N1 cells and in Molt-4 T cells, both of which were devoid of apoptosis induced by anti-Fas antibody in the absence of bisindolylmaleimide VIII, and in Jurkat and CEM-6 T cells, which showed slight and moderate apoptotic responses, respectively, to low levels of Fas stimulation. Potentiation of Fas-mediated apoptosis by bisindolylmaleimide VIII was selective for activated, rather than non-activated, T cells, and was Fas-dependent, as it was not observed in T cells from Fas-deficient lpr/lpr mice. Administration of bisindolylmaleimide VIII to rats during autoantigen stimulation prevented the development of symptoms of T cell-mediated autoimmune diseases in two models, the Lewis rat model of experimental allergic encephalitis and the Lewis adjuvant arthritis model. Thus, the use of agents such as bisindolylmaleimide VIII may be therapeutically useful for supporting more effective elimination of detrimental cells through enhancement of Fas-dependent apoptosis signaling.
    35 schema:genre article
    36 schema:inLanguage en
    37 schema:isAccessibleForFree false
    38 schema:isPartOf N4e1ba209f4114955a02ea8af151c03bb
    39 N4ff05c3b3eab47bfa33d74fed66ed41f
    40 sg:journal.1113716
    41 schema:keywords FA
    42 Fas stimulation
    43 Fas-deficient lpr/lpr mice
    44 Fas-dependent apoptosis
    45 Fas-mediated apoptosis
    46 Jurkat
    47 Lewis rat model
    48 MOLT-4 T cells
    49 Potentiation of Fas
    50 T cells
    51 VIII
    52 absence
    53 adjuvant arthritis model
    54 administration
    55 agents
    56 allergic encephalitis
    57 anti-Fas antibody
    58 antibodies
    59 apoptosis
    60 apoptotic response
    61 arthritis model
    62 astrocytoma 1321N1 cells
    63 autoantigen stimulation
    64 autoimmune diseases
    65 bisindolylmaleimide VIII
    66 cell-mediated autoimmune disease
    67 cells
    68 consequences
    69 detrimental cells
    70 detrimental consequences
    71 development
    72 development of symptoms
    73 disease
    74 effective elimination
    75 elimination
    76 elimination of cells
    77 encephalitis
    78 enhancement
    79 experimental allergic encephalitis
    80 human astrocytoma 1321N1 cells
    81 levels
    82 low levels
    83 lpr mice
    84 lpr/lpr mice
    85 mice
    86 model
    87 more effective elimination
    88 potentiation
    89 rat model
    90 rats
    91 response
    92 severe detrimental consequences
    93 stimulation
    94 symptoms
    95 use
    96 use of agents
    97 schema:name Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases
    98 schema:pagination 42-48
    99 schema:productId N53d628592e25423c874f0ba582d55221
    100 N73641924827444289293a47d4f3d3169
    101 N95169613fa1049679cd87d43947ebee4
    102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001523482
    103 https://doi.org/10.1038/4723
    104 schema:sdDatePublished 2022-05-20T07:20
    105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    106 schema:sdPublisher N9e4c7cb0372241c5b26a76b2c5d2152b
    107 schema:url https://doi.org/10.1038/4723
    108 sgo:license sg:explorer/license/
    109 sgo:sdDataset articles
    110 rdf:type schema:ScholarlyArticle
    111 N000b1ce5a3e14c00bcac5750e62f568b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Mice
    113 rdf:type schema:DefinedTerm
    114 N0ad18f11321e4b56ba167b1374935aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Lymphocyte Activation
    116 rdf:type schema:DefinedTerm
    117 N11269747941444748e0c9e482aa4a3db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Tumor Cells, Cultured
    119 rdf:type schema:DefinedTerm
    120 N1d0cb05d77064ed0b54af6d1d8ada675 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Rats, Inbred Lew
    122 rdf:type schema:DefinedTerm
    123 N211d33258e2e4a97aa13281316ae42a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Rats
    125 rdf:type schema:DefinedTerm
    126 N2bf39facd7f64caaae5aa0be1c85a1fd schema:affiliation grid-institutes:grid.265892.2
    127 schema:familyName Lui
    128 schema:givenName Di
    129 rdf:type schema:Person
    130 N32b633ae1b6c49b084cf4a547014f72c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name T-Lymphocytes
    132 rdf:type schema:DefinedTerm
    133 N3acfbc410acd4d0dbe3902eaf30cb2aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Encephalomyelitis, Autoimmune, Experimental
    135 rdf:type schema:DefinedTerm
    136 N420d6d0b114b457097c327a426b09b73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Animals
    138 rdf:type schema:DefinedTerm
    139 N4e1ba209f4114955a02ea8af151c03bb schema:issueNumber 1
    140 rdf:type schema:PublicationIssue
    141 N4ff05c3b3eab47bfa33d74fed66ed41f schema:volumeNumber 5
    142 rdf:type schema:PublicationVolume
    143 N53d628592e25423c874f0ba582d55221 schema:name pubmed_id
    144 schema:value 9883838
    145 rdf:type schema:PropertyValue
    146 N586899d6e2254b3f88a9502913dab3e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Humans
    148 rdf:type schema:DefinedTerm
    149 N60c24a234a1e422e92762d8c57c32e49 rdf:first sg:person.0664616100.38
    150 rdf:rest Naff3fe61751241218a2cf597e383f7b8
    151 N6d1ad305412241b3969df6ed4f30dd9c rdf:first sg:person.01117126520.59
    152 rdf:rest Nfc18329652494fb2b3056459b778abe9
    153 N6fb0c12b61f44a869ee463cae739ddd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Mice, Inbred MRL lpr
    155 rdf:type schema:DefinedTerm
    156 N7073c5743cf6499f943027a989e43343 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Indoles
    158 rdf:type schema:DefinedTerm
    159 N73641924827444289293a47d4f3d3169 schema:name doi
    160 schema:value 10.1038/4723
    161 rdf:type schema:PropertyValue
    162 N77f03af1a3e045c7b772651157cb4c6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Apoptosis
    164 rdf:type schema:DefinedTerm
    165 N91ee753773044917aba16f7eb5e3c103 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Tumor Necrosis Factor-alpha
    167 rdf:type schema:DefinedTerm
    168 N95169613fa1049679cd87d43947ebee4 schema:name dimensions_id
    169 schema:value pub.1001523482
    170 rdf:type schema:PropertyValue
    171 N9e4c7cb0372241c5b26a76b2c5d2152b schema:name Springer Nature - SN SciGraph project
    172 rdf:type schema:Organization
    173 Na8d4a0ec6b0f4d568e4f7f2079274e48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Arthritis, Experimental
    175 rdf:type schema:DefinedTerm
    176 Naff3fe61751241218a2cf597e383f7b8 rdf:first sg:person.0724445616.42
    177 rdf:rest Nce972b2b18d8428db4a22468346c140b
    178 Nb6f81b2ddfef424fb9cfb4dc69c512a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Maleimides
    180 rdf:type schema:DefinedTerm
    181 Nbbaf71b217044e158a30a008503dceb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Enzyme Inhibitors
    183 rdf:type schema:DefinedTerm
    184 Nc27fa456b14840d5b3ee815efaeca381 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Autoimmune Diseases
    186 rdf:type schema:DefinedTerm
    187 Ncda44151da48412484bf38edc6c95df3 rdf:first sg:person.01076605634.02
    188 rdf:rest rdf:nil
    189 Nce972b2b18d8428db4a22468346c140b rdf:first sg:person.016612437322.42
    190 rdf:rest N6d1ad305412241b3969df6ed4f30dd9c
    191 Nd377ae7010604cd2966680b78f88eb14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name fas Receptor
    193 rdf:type schema:DefinedTerm
    194 Nd8ca504bf7a24edb95a89af18cbd1169 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Jurkat Cells
    196 rdf:type schema:DefinedTerm
    197 Ndc773819fbaf43ae93c8dbf148f3961a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Dose-Response Relationship, Drug
    199 rdf:type schema:DefinedTerm
    200 Ndca9994a956f4a909ab1181b92b5eee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Disease Models, Animal
    202 rdf:type schema:DefinedTerm
    203 Nea98e90fd533442f886dc32607392885 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Protein Kinase C
    205 rdf:type schema:DefinedTerm
    206 Nfc18329652494fb2b3056459b778abe9 rdf:first N2bf39facd7f64caaae5aa0be1c85a1fd
    207 rdf:rest Ncda44151da48412484bf38edc6c95df3
    208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    209 schema:name Medical and Health Sciences
    210 rdf:type schema:DefinedTerm
    211 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    212 schema:name Immunology
    213 rdf:type schema:DefinedTerm
    214 sg:grant.2434637 http://pending.schema.org/fundedItem sg:pub.10.1038/4723
    215 rdf:type schema:MonetaryGrant
    216 sg:grant.2546217 http://pending.schema.org/fundedItem sg:pub.10.1038/4723
    217 rdf:type schema:MonetaryGrant
    218 sg:grant.2567549 http://pending.schema.org/fundedItem sg:pub.10.1038/4723
    219 rdf:type schema:MonetaryGrant
    220 sg:grant.2667883 http://pending.schema.org/fundedItem sg:pub.10.1038/4723
    221 rdf:type schema:MonetaryGrant
    222 sg:journal.1113716 schema:issn 1078-8956
    223 1546-170X
    224 schema:name Nature Medicine
    225 schema:publisher Springer Nature
    226 rdf:type schema:Periodical
    227 sg:person.01076605634.02 schema:affiliation grid-institutes:grid.265892.2
    228 schema:familyName Jope
    229 schema:givenName Richard S.
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076605634.02
    231 rdf:type schema:Person
    232 sg:person.01117126520.59 schema:affiliation grid-institutes:grid.265892.2
    233 schema:familyName Wang
    234 schema:givenName Zheng
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117126520.59
    236 rdf:type schema:Person
    237 sg:person.016612437322.42 schema:affiliation grid-institutes:grid.265892.2
    238 schema:familyName Yang
    239 schema:givenName Pingar
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612437322.42
    241 rdf:type schema:Person
    242 sg:person.0664616100.38 schema:affiliation grid-institutes:grid.265892.2
    243 schema:familyName Zhou
    244 schema:givenName Tong
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38
    246 rdf:type schema:Person
    247 sg:person.0724445616.42 schema:affiliation grid-institutes:grid.265892.2
    248 schema:familyName Song
    249 schema:givenName Ling
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724445616.42
    251 rdf:type schema:Person
    252 sg:pub.10.1007/978-1-4615-1891-4_18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026925757
    253 https://doi.org/10.1007/978-1-4615-1891-4_18
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1038/332843a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030288808
    256 https://doi.org/10.1038/332843a0
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1038/356314a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041635124
    259 https://doi.org/10.1038/356314a0
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1038/373438a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045725490
    262 https://doi.org/10.1038/373438a0
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1038/373441a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049599122
    265 https://doi.org/10.1038/373441a0
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1038/373444a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037666095
    268 https://doi.org/10.1038/373444a0
    269 rdf:type schema:CreativeWork
    270 grid-institutes:grid.265892.2 schema:alternateName Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA
    271 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA
    272 schema:name Department of Psychiatry and Behavioral Neurobiology The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA
    273 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, 35294, Birmingham, Alabama, USA
    274 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...